Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-14-006664)

Filing Details

Accession Number:: 0001209191-14-006664
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2014-02-03 20:34:00
Reporting Period:: 2014-01-30

Filing Date:: 2014-02-03
Accepted Time:: 2014-02-03 20:34:00
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1515673	Ultragenyx Pharmaceutical Inc.	RARE	Pharmaceutical Preparations (2834)	272546083

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1397266	K Matthew Fust	C/O Ultragenyx Pharmaceutical Inc. 60 Leveroni Court Novato CA 94949		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2014-01-30	5,000	$21.00	5,000	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Acquisiton	2014-01-30	17,500	$0.00	17,500	$21.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
17,500		2024-01-29	No	4	A	Direct

Footnotes

Purchase of shares in Issuer's directed share program in connection with the Issuer's initial public offering.
The option shall vest with respect to 1/36th of the shares monthly such that the options shall be fully vested on the third anniversary of the grant date.